Home » Headlines » Currently Reading:

Morning Headlines 5/7/13

May 6, 2013 Headlines No Comments

Greenway Reports Fiscal 2013 Third-Quarter Results

Following lowered year-end forecasts that caused a 22 percent one-day drop in stock price last week, Greenway sees an additional 2.8 percent drop after releasing its Q3 earnings report. The company suffered a $2.8 million net loss from operations over the quarter due to fewer one-time system sales and lower training and consulting revenue. Shares closed at $11.94, $0.11 higher than their 52-week low.

Electronic Health Information Exchange Governance Framework Released

ONC releases its regulatory framework for health information exchanges. It establishes a common foundation and spells out regulatory exchange conditions for public and private HIEs to align with.

CHIME Calls For One-Year Extension of Stage 2 Meaningful Use

The College of Healthcare Information Management Executives sends a letter to six Republican senators recommending a one-year extension to Stage 2 Meaningful Use before progressing to Stage 3.

ATA kicks off its annual meeting with a call for Mercy

The American Telemedicine Association kicked off its annual meeting in Austin, TX with Mercy Health President and CEO Lynn Britton giving the keynote address, in which he spoke of about telemedicine and the return on investment Mercy Health realized from its initiatives.



HIStalk Featured Sponsors

     







Text Ads


RECENT COMMENTS

  1. It seems that every innovation in the past 50 years has claimed that it would save money and lives. There…

  2. Well, this is predicting the future, and my crystal ball is cloudy and cracked. But my basic thesis about Meditech?…

  3. RE Judy Faulkner's foundation wishes: Different area, but read up on the Barnes Foundation to see how things work out…

  4. Meditech certainly benefited from Cerner and Allscripts stumbles and before that the failures of ECW and Athena’s inpatient expansions. I…

  5. Yes, Meditech will talk your ears off about Expanse. There are multiple factors at play here which undercut both Meditech…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors